China’s approval of a first dual BAFF/APRIL therapy in IgA [...]

Racura Oncology has treated the first patient in its Harness-1 [...]

EMBARC has announced its intention to collaborate with Insmed on [...]

Al-S Pharma reports Phase 2 AP-101 data in ALS showing [...]

Thalia Therapeutics has agreed a Sanmirna acquisition and £2.75m fundraise [...]

Absci has reported positive interim Phase 1 data for ABS-201, [...]

Kayentis has launched an AI-powered eConsent module designed to improve [...]

Orphan Therapeutics Accelerator has expanded its development network for ultra-rare [...]

The first patients have been dosed in a Phase 2 [...]

CORXEL Pharmaceuticals reported positive Phase 2 results for oral GLP-1 [...]